A multicenter, randomized, double-blind, placebo- and active-controlled study of DVS-233 [desvenlafaxine; Pristiq] SR [slow release] for treatment of vasomotor symptoms associated with menopause
Phase of Trial: Phase III
Latest Information Update: 14 May 2007
At a glance
- Drugs Desvenlafaxine; Tibolone
- Indications Hot flashes; Menopausal syndrome; Menopause
- Focus Registrational; Therapeutic Use
- 14 May 2007 Status changed from recruiting to completed.
- 09 May 2007 Results have been published
- 08 Nov 2005 New trial record.